• Je něco špatně v tomto záznamu ?

The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan

K. Zachová, E. Bartheldyová, F. Hubatka, M. Křupka, N. Odehnalová, P. Turánek Knötigová, N. Vaškovicová, K. Sloupenská, R. Hromádka, E. Paulovičová, R. Effenberg, M. Ledvina, M. Raška, J. Turánek

. 2024 ; 332 (-) : 121844. [pub] 20240123

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006483

Anti-viral and anti-tumor vaccines aim to induce cytotoxic CD8+ T cells (CTL) and antibodies. Conserved protein antigens, such as p24 from human immunodeficiency virus, represent promising component for elicitation CTLs, nevertheless with suboptimal immunogenicity, if formulated as recombinant protein. To enhance immunogenicity and CTL response, recombinant proteins may be targeted to dendritic cells (DC) for cross presentation on MHCI, where mannose receptor and/or other lectin receptors could play an important role. Here, we constructed liposomal carrier-based vaccine composed of recombinant p24 antigen bound by metallochelating linkage onto surface of nanoliposomes with surface mannans coupled by aminooxy ligation. Generated mannosylated proteonanoliposomes were analyzed by dynamic light scattering, isothermal titration, and electron microscopy. Using murine DC line MutuDC and murine bone marrow derived DC (BMDC) we evaluated their immunogenicity and immunomodulatory activity. We show that p24 mannosylated proteonanoliposomes activate DC for enhanced MHCI, MHCII and CD40, CD80, and CD86 surface expression both on MutuDC and BMDC. p24 mannosylated liposomes were internalized by MutuDC with p24 intracellular localization within 1 to 3 h. The combination of metallochelating and aminooxy ligation could be used simultaneously to generate nanoliposomal adjuvanted recombinant protein-based vaccines versatile for combination of recombinant antigens relevant for antibody and CTL elicitation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006483
003      
CZ-PrNML
005      
20240423155318.0
007      
ta
008      
240412e20240123enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.carbpol.2024.121844 $2 doi
035    __
$a (PubMed)38431385
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Zachová, K $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, Czech Republic
245    14
$a The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan / $c K. Zachová, E. Bartheldyová, F. Hubatka, M. Křupka, N. Odehnalová, P. Turánek Knötigová, N. Vaškovicová, K. Sloupenská, R. Hromádka, E. Paulovičová, R. Effenberg, M. Ledvina, M. Raška, J. Turánek
520    9_
$a Anti-viral and anti-tumor vaccines aim to induce cytotoxic CD8+ T cells (CTL) and antibodies. Conserved protein antigens, such as p24 from human immunodeficiency virus, represent promising component for elicitation CTLs, nevertheless with suboptimal immunogenicity, if formulated as recombinant protein. To enhance immunogenicity and CTL response, recombinant proteins may be targeted to dendritic cells (DC) for cross presentation on MHCI, where mannose receptor and/or other lectin receptors could play an important role. Here, we constructed liposomal carrier-based vaccine composed of recombinant p24 antigen bound by metallochelating linkage onto surface of nanoliposomes with surface mannans coupled by aminooxy ligation. Generated mannosylated proteonanoliposomes were analyzed by dynamic light scattering, isothermal titration, and electron microscopy. Using murine DC line MutuDC and murine bone marrow derived DC (BMDC) we evaluated their immunogenicity and immunomodulatory activity. We show that p24 mannosylated proteonanoliposomes activate DC for enhanced MHCI, MHCII and CD40, CD80, and CD86 surface expression both on MutuDC and BMDC. p24 mannosylated liposomes were internalized by MutuDC with p24 intracellular localization within 1 to 3 h. The combination of metallochelating and aminooxy ligation could be used simultaneously to generate nanoliposomal adjuvanted recombinant protein-based vaccines versatile for combination of recombinant antigens relevant for antibody and CTL elicitation.
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a antigeny $7 D000941
650    _2
$a dendritické buňky $7 D003713
650    12
$a HIV-1 $7 D015497
650    _2
$a liposomy $x metabolismus $7 D008081
650    _2
$a mannany $x metabolismus $7 D008351
650    _2
$a rekombinantní proteiny $x metabolismus $7 D011994
650    12
$a vakcíny proti AIDS $x imunologie $7 D016915
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bartheldyová, E $u C2P NEXARS, The Campus Science Park, Palachovo náměstí 2, Brno, Czech Republic
700    1_
$a Hubatka, F $u C2P NEXARS, The Campus Science Park, Palachovo náměstí 2, Brno, Czech Republic
700    1_
$a Křupka, M $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, Czech Republic
700    1_
$a Odehnalová, N $u C2P NEXARS, The Campus Science Park, Palachovo náměstí 2, Brno, Czech Republic
700    1_
$a Turánek Knötigová, P $u C2P NEXARS, The Campus Science Park, Palachovo náměstí 2, Brno, Czech Republic
700    1_
$a Vaškovicová, N $u Faculty of Medicine, Masaryk University, Kamenice 5, Brno, Czech Republic
700    1_
$a Sloupenská, K $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, Czech Republic
700    1_
$a Hromádka, R $u C2P NEXARS, The Campus Science Park, Palachovo náměstí 2, Brno, Czech Republic
700    1_
$a Paulovičová, E $u Center for Glycomics, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, Slovakia
700    1_
$a Effenberg, R $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Technická 5, Prague, Czech Republic
700    1_
$a Ledvina, M $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Technická 5, Prague, Czech Republic
700    1_
$a Raška, M $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, Czech Republic. Electronic address: milan.raska@upol.cz
700    1_
$a Turánek, J $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, Czech Republic; C2P NEXARS, The Campus Science Park, Palachovo náměstí 2, Brno, Czech Republic; Institute of Clinical Immunology & Allergology, Charles University Prague and University Hospital, Hradec Kralove, Sokolská 581, Hradec Kralove, Czech Republic. Electronic address: turanek@seznam.cz
773    0_
$w MED00006149 $t Carbohydrate polymers $x 1879-1344 $g Roč. 332 (20240123), s. 121844
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38431385 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155314 $b ABA008
999    __
$a ok $b bmc $g 2080838 $s 1216250
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 332 $c - $d 121844 $e 20240123 $i 1879-1344 $m Carbohydrate polymers $n Carbohydr Polym $x MED00006149
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace